About Sundyota Numandis
Sundyota Numandis is a Healthcare company based in Ahmedabad (India) founded in 2003. Provider of probiotics, nutraceuticals, and phytopharmaceuticals in healthcare sectors. The company has 310 employees. Its Indian entity Sundyota Numandis Pharmaceuticals Private Limited reported revenue of ₹174 Cr. Sundyota Numandis offers products and services including Superflora™ GG and Mobiwalk™. Its focus areas include Nutraceuticals, Probiotics and Supplements, Gut Health Products and Pharmaceuticals.
Company details
Sundyota Numandis is recognized as a healthcare group that was established in 2003 to promote prevention and management of health through evidence-based nutraceuticals, microbiome, and phytopharmaceuticals. Products are derived from natural sources and are backed by extensive scientific research, focusing on specific needs like gut health and immunity. Various verticals, including B2B and B2C operations, are operated globally with facilities in India and Switzerland. Ethical practices and innovation are emphasized in the development of these solutions, aiming for effective and safe health promotion.
- Headquarters Ahmedabad, India
- Employees 310
- SectorsHealthcare
- Email••••••••
- Social LinkedIn YouTube
- Legal Name Sundyota Numandis Pharmaceuticalsprivate Limited
- Date of Incorporation 29 May, 2003
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹174 Cr
FY 2025 · +20% YoY
- Net Profit₹26.46 Cr
FY 2025 · 15% margin
- EBITDA₹45.76 Cr
FY 2025 · 26% margin
- Employee Count310
Associated legal entities of Sundyota Numandis
Sundyota Numandis operates through Sundyota Numandis Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sundyota Numandis Pharmaceuticals Private Limited CIN U24239GJ2003PTC042438 | Active | 29 May 2003 | Ahmedabad, Gujarat | ₹174 Cr | 310 | 2 | View details |
Products & Services of Sundyota Numandis
Sundyota Numandis offers a comprehensive portfolio of products and services, including Superflora™ GG and Mobiwalk™.
Probiotics are developed for improving gut health through natural formulations.
Products for joint care are offered as part of nutraceutical solutions.
Apps and channels of Sundyota Numandis
its YouTube channel Sundyota Numandis Group of Companies has 193 subscribers and 4 videos.
Videos from Sundyota Numandis
The most watched videos on Sundyota Numandis's YouTube channel, Sundyota Numandis Group of Companies (193 subscribers). Click a video to play it here.
More on Sundyota Numandis Group of Companies.
Board of directors of Sundyota Numandis Pharmaceuticals Private Limited (Sundyota Numandis)
Sundyota Numandis Pharmaceuticals Private Limited is the primary company behind Sundyota Numandis. The board of Sundyota Numandis Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Dinesh Kumar Arora, appointed in 2003. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dinesh Kumar Arora DIN 00375442 | Managing Director | 29 May 2003 | 23 yrs 4 mo | Sundyota Numandis Pharmaceuticals Private Limited |
| Poonam Arora DIN 00375577 | Director | 24 Jul 2012 | 14 yrs 2 mo | Sundyota Numandis Pharmaceuticals Private Limited |
Financials of Sundyota Numandis
Figures of Sundyota Numandis Pharmaceuticals Private Limited, the primary company behind Sundyota Numandis, for FY 2025. Revenue was ₹174 Cr (+20% year on year). Net profit was ₹26.46 Cr (15% margin). EBITDA was ₹45.76 Cr (26% margin). Revenue has grown at a compounded annual rate of +16% over three years and +9% over five years.
- ₹174 CrRevenue · FY 2025 · +20% YoY
- ₹26.46 CrNet profit · 15% margin
- ₹45.76 CrEBITDA · 26% margin
- ₹3.30 CrPaid-up capital
- 310Employees (provident fund records)
- +16%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sundyota Numandis Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Sundyota Numandis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Sundyota Numandis
Websites that share an audience with Sundyota Numandis (sundyotanumandis.com).
Websites whose visitors overlap most with Sundyota Numandis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| spectrumpharmatech.com | 71% | 1.4K | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sundyota Numandis
Complete news archive for Sundyota Numandis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sundyota Numandis
Sundyota Numandis was founded in 2003.
Sundyota Numandis is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Sundyota Numandis has 310 employees.
The primary company behind Sundyota Numandis, Sundyota Numandis Pharmaceuticals Private Limited, reported revenue of ₹174 Cr for FY 2025, up 20% year on year.
Sundyota Numandis is recognized as a healthcare group that was established in 2003 to promote prevention and management of health through evidence-based nutraceuticals, microbiome, and phytopharmaceuticals. Products are derived from natural sources and are backed by extensive scientific research, focusing on specific needs like gut health and immunity. Various verticals, including B2B and B2C operations, are operated globally with facilities in India and Switzerland. Ethical practices and innovation are emphasized in the development of these solutions, aiming for effective and safe health promotion.
Sundyota Numandis offers Superfloraâ„¢ GG and Mobiwalkâ„¢.
Sundyota Numandis operates through Sundyota Numandis Pharmaceuticals Private Limited.
The legal entities of Sundyota Numandis currently have 2 directors, including Poonam Arora, Dinesh Kumar Arora.